12 results on '"mediterranean fever"'
Search Results
2. Familial Mediterranean Fever in a 28-Year-Old Male Presented as a Painless Massive Pleural Effusion.
- Author
-
Dimeas G, Dimeas IE, Papacharalampous K, Chalvatzoulis E, and Daniil Z
- Abstract
This case describes the first patient with familial Mediterranean fever (FMF) with massive left pleural effusion as the first clinical manifestation, to whom a video-assisted thoracoscopic surgery was performed to support the diagnosis. The patient was a 28-year-old male, who presented with dry cough and dyspnea but no fever. The lab findings showed hypoxemia (partial pressure of oxygen
- Published
- 2023
- Full Text
- View/download PDF
3. Juvenile-onset systemic lupus erythematosus and MEFV polymorphism: A case-control association study among Iranian children.
- Author
-
Mohebichamkhorami F, Shiari R, Afzali S, and Farivar S
- Subjects
- Humans, Child, Iran, Case-Control Studies, Genotype, Pyrin genetics, Polymorphism, Genetic, Lupus Erythematosus, Systemic genetics, Lupus Erythematosus, Systemic pathology
- Abstract
Introduction and Objectives: This study is designed to evaluate the potential influences of Mediterranean fever gene (MEFV) gene polymorphism on systemic lupus erythematosus (SLE) in a cohort of juvenile patients. A case-control study was performed on Iranian patients with a mixed ethnicity population., Patients and Methods: Genotypes of 50 juvenile cases, and 85 healthy controls were investigated for identifying M694V and R202Q polymorphism. Genotyping was done utilizing amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to detect M694V and R202Q mutations, respectively., Main Findings: Our study indicates significant differences in the alleles and genotypes frequencies of MEFV polymorphism between SLE patients and healthy controls (P<0.05). Also, an association was found between renal involvement (50% vs. 8.3%, P=0.000, OR=0.91, 95% CI=0.30-0.278) in juvenile SLE patients and M694V polymorphism incident; But there was no association with other clinical manifestations., Principal Conclusion: We found a significant association between R202Q and M694V polymorphism of the MEFV gene and susceptibility to SLE in the studied population; However, further studies on detailed characterization of these polymorphisms' impacts on the key elements responsible for SLE pathogenesis is of great importance., (Copyright © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. [The analysis of secondary AA-amyloidosis current etiology and its influence on the approaches for diagnosis and treatment].
- Author
-
Rameev VV, Kozlovskaya LV, Rameeva AS, Novikov AV, and Barsuk MV
- Subjects
- Humans, S100A12 Protein, Inflammation, Serum Amyloid A Protein metabolism, Amyloidosis
- Abstract
Aim: To investigate an influence of the currently changed etiologic structure of AA-amyloidosis on the diagnosis and treatment tactics., Materials and Methods: In 110 patients with АА-amyloidosis followed during full disease duration (1 month 29 years) etiology, clinical manyfestations and approaches to diagnose and treatment of AA-amyloidosis were evaluated. With ELISA levels of amyloid precursor acute phase inflammation reactant SAA and neutrophil activity marker S100A12 were measured., Results: Among the most common causes of AA-amyloidosis at the present stage, in addition to RA (40.3%), a significant place is occupied by a group of diseases with a predominantly autoinflammatory mechanism (53.73%). To confirm the autoinflammatory mechanism of the predisposing disease it is recommended to study a highly sensitive parameter serum protein S100A12. An effective marker of the risk of AA-amyloidosis progression, especially in patients with subclinical activity of inflammatory disease, is a high level of production of amyloidogenic protein-a precursor of SAA.
- Published
- 2021
- Full Text
- View/download PDF
5. Epidemiological assessment of 5598 brucellosis inpatients in Spain (1997-2015).
- Author
-
Rodríguez-Alonso B, Almeida H, Alonso-Sardón M, Velasco-Tirado V, Romero-Alegria Á, Pardo-Lledias J, López-Bernus A, Pérez Arellano JL, and Belhassen-García M
- Subjects
- Adolescent, Adult, Aged, Brucella, Brucellosis mortality, Databases, Factual, Female, Hospitalization, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Retrospective Studies, Risk Factors, Spain epidemiology, Young Adult, Brucellosis epidemiology, Inpatients statistics & numerical data
- Abstract
Brucellosis remains one of the main zoonoses worldwide. Epidemiological data on human brucellosis in Spain are scarce. The objective of this study was to assess the epidemiological characteristics of inpatient brucellosis in Spain between 1997 and 2015. A retrospective longitudinal descriptive study was performed. Data were requested from the Health Information Institute of the Ministry of Health and Equality, which provided us with the Minimum Basic Data Set of patients admitted to the National Health System. We also obtained data published in the System of Obligatory Notifiable Diseases. A total of 5598 cases were registered. The period incidence rate was 0.67 (95% CI 0.65-0.68) cases per 100 000 person-years. We observed a progressive decrease in the number of cases and annual incidence rates. A total of 3187 cases (56.9%) came from urban areas. The group most at risk comprised men around the fifth decade of life. The average (±s.d.) hospital stay was 12.6 days (±13.1). The overall lethality rate of the cohort was 1.5%. The number of inpatients diagnosed with brucellosis decreased exponentially. The group of patients with the highest risk of brucellosis in our study was males under 45 years of age and of urban origin. The lethality rate has reduced to minimum values. It is probable that hospital discharge records could be a good database for the epidemiological analysis of the hospital management of brucellosis and offer a better information collection system than the notifiable diseases system (EDO in Spanish).
- Published
- 2021
- Full Text
- View/download PDF
6. Sonoelastographic Assessment of the Achilles Tendon in Familial Mediterranean Fever Patients: Comparison With Healthy Subjects.
- Author
-
Evran S, Beker-Acay M, Saracli S, Acay A, Kacar E, and Kaya F
- Abstract
Introduction and Objective: This study aims at using sonoelastography as a novel technique to evaluate the stiffness and thickness of Achilles tendons in familial Mediterranean fever (FMF) patients., Methods: Achilles tendons of 26 FMF patients and 23 control subjects were assessed with ultrasound and real-time sonoelastography. The Achilles tendons were divided into the distal, middle, and proximal thirds for elastographic image evaluation. Tendons were classified into three main types according to their elasticity features: grade 1 blue (hardest tissue) to green (hard tissue); grade 2, yellow (soft tissue); and grade 3, red (softest tissue). Tendons of the groups were compared in terms of thickness and stiffness., Results: There were no significant differences in thickness and stiffness of the Achilles tendon between FMF patients and controls (p>0.05). Sonoelastography of Achilles tendons of FMF patients displayed no relationship between FMF and tendinopathy. Conclusion: This issue should be explored in prospective studies in larger groups., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2020, Evran et al.)
- Published
- 2020
- Full Text
- View/download PDF
7. MEFV c.2230G>T p.(Ala744Ser) rs61732874 previously misclassified as pathogenic variant due to lack of a population specific database.
- Author
-
Alsubaie L, Alkhalaf R, Aloraini T, Amoudi M, Swaid A, Al Mutairi F, Alfadhel M, Eyaid W, Sewairi W, and Alfares A
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Exome, Female, Genetics, Population, Humans, Infant, Male, Middle Aged, Saudi Arabia, Young Adult, Familial Mediterranean Fever genetics, Gene Frequency, Pyrin genetics
- Abstract
Background: Familial Mediterranean fever is a hereditary inflammatory disorder caused by variants in MEFV. c.2230G>T p.(Ala744Ser) rs61732874 is considered to be an established pathogenic variant in MEFV, but in this study we provide a complete evaluation that suggests this variant is likely benign., Methods: Using an in-house exome database from 924 individuals, we extracted all individuals harboring this variant for clinical, laboratory, and familial evaluation., Results: We identified the variant in 58 individuals from 39 families. The allele frequency of this variant in our database is 4.2%. None of the identified individuals match the diagnosis of Familial Mediterranean Fever. Using the American College of Medical Genetics and Genomics guidelines for variant classification, this variant is classified as likely benign and not pathogenic., Conclusion: Conflicting evidence about variants creates challenges for testing laboratories and impacts patient care. Sharing information drawn mainly from underrepresented populations and clinical phenotyping are important tools for precise curation of genetic variants., (© 2020 John Wiley & Sons Ltd/University College London.)
- Published
- 2020
- Full Text
- View/download PDF
8. The role of Rhipicephalus sanguineus ticks parasitizing dogs in the spread of tick-borne rickettsial pathogens in the city of Sevastopol.
- Author
-
Alieva EE, Bondarenko EI, Maliy KD, Shvalov AN, Verbenets EA, and Gafarova MT
- Abstract
The occurrence of Mediterranean fever with periods of increase and decrease has been recorded in the Crimean peninsula. The city of Sevastopol and its vicinity are known endemic areas for this disease. Some of the most active agents in the spread of this rickettsiosis are feral and abandoned dogs. The aim of this study was to test ticks parasitizing dogs in Sevastopol for the presence of Rickettsia using molecular methods. The testing of ticks was carried out using real-time PCR and the 'Real Best DNA Rickettsia species' kit (AO 'Vector-Best') followed by sequence identification of the rickettsial DNA detected. The DNA marker for Rickettsia species (a conservative area of citrate synthase gene, glt A) was detected in 16 of 84 (19.1%) samples of Rhipicephalus sanguineus ticks tested. Larger fragments of glt A, omp A and sca 4 were amplified and sequenced for 10 of 16 PCR-positive samples. Rickettsia DNA amplified from eight of the samples matched the sequence of Rickettsia conorii conorii Malish, the causative agent of Mediterranean fever. The sequences of Rickettsia DNA from two other ticks had the closest match to homologous fragments of Rickettsia massiliae , a pathogenic spotted fever rickettsia that was identified in the Crimean Peninsula for the first time as part of this study. The detection of two pathogenic species of Rickettsia in the studied ticks suggests the potential for two rickettsial diseases in the region and warrants further epidemiological and clinical studies., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
9. Immunological Rare Diseases.
- Author
-
Baldovino S, Menegatti E, Roccatello D, and Sciascia S
- Subjects
- Humans, Immune System physiopathology, Immune System Diseases diagnosis, Immune System Diseases epidemiology, Immune System Diseases therapy, Prognosis, Rare Diseases diagnosis, Rare Diseases epidemiology, Rare Diseases therapy, Risk Factors, Immune System immunology, Immune System Diseases immunology, Rare Diseases immunology
- Abstract
The immune system is delegated to defend the body from attacks from outside or inside. Many diseases can affect immune system reducing its ability to defend self or inducing an abnormal response against external or internal antigens. Rare diseases affecting immune system present some issue in common with other rare diseases and some peculiarities due to the huge variability in the disease's expression. However, a correct estimation of the epidemiology of rare disorders is necessary for evaluating the prognosis and the responses to new therapies, for planning proper public health services, and finally to establish fair and sustainable prices for innovative medicines. Due to the enormous number of different rare immunological diseases, in this chapter we are going to analyse some of them that can be considered paradigmatic of the various expressions of disease.
- Published
- 2017
- Full Text
- View/download PDF
10. [Not Available].
- Author
-
Müller J, Oberlin D, and Nüesch R
- Subjects
- Colchicine therapeutic use, Diagnosis, Differential, Familial Mediterranean Fever drug therapy, Female, Fever of Unknown Origin drug therapy, Humans, Middle Aged, Recurrence, Familial Mediterranean Fever diagnosis, Fever of Unknown Origin etiology
- Published
- 2016
- Full Text
- View/download PDF
11. [Cardiac tamponade as first manifestation in Mediterranean fever with autosomal dominant form].
- Author
-
Sánchez Ferrer F, Martinez Villar M, Fernández Bernal A, Martín de Lara I, and Paya Elorza I
- Subjects
- Adolescent, Familial Mediterranean Fever diagnosis, Genes, Dominant, Humans, Male, Cardiac Tamponade etiology, Familial Mediterranean Fever complications, Familial Mediterranean Fever genetics
- Abstract
Familial Mediterranean fever (FMF) is a hereditary disease characterized by brief, recurring and self-limited episodes of fever and pain with inflammation, of one or several serous (peritoneum, pleura, pericardium, synovial or vaginal tunic of the testicle). Amyloidosis is its more important complication and the principal reason of death in the cases in which it appears. Diagnosis is based on the clinic and is confirmed by genetic tests. The treatment with Colchicine (0,02-0,03 mg/kg/day) prevents the recurrence of FMF attacks and the development of secondary (AA) amyloidosis. We report a case of a 13-year-old child in which FMF was diagnosed after several coincidental episodes with fever, pericarditis and cardiac tamponade. The genetic confirmation showed an autosomal dominant inheritance that is less frecuent than the recesive form, in this disease., (Copyright © 2013 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
12. Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population.
- Author
-
Yigit S, Inanir A, Tekcan A, Inanir S, Tural S, and Ates O
- Subjects
- Adult, Case-Control Studies, Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Minisatellite Repeats, Sequence Analysis, DNA, Turkey, Fibromyalgia genetics, Interleukin-4 genetics, Polymorphism, Genetic
- Abstract
Purpose: Fibromyalgia (FM) syndrome is a form of non-articular rheumatism characterized by long term and widespread musculoskeletal pain, morning stiffness, sleep disturbance, paresthesia, and pressure hyperalgesia at characteristic sites, called soft tissue tender points. The etiology of FM is still obscure. Genetic factors may predispose individuals to FM. Cytokines may play a role in the pathophysiology of FM. The aim of this study was to investigate the interleukin-4 (IL-4) 70 bp VNTR variations in Turkish patients with FM and evaluate if there was an association with clinical features, especially between these polymorphisms., Methods: The study included 300 patients with FM and 270 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR) for the IL-4 gene 70 bp VNTR polymorphisms., Results: There was statistically significant difference between the groups with respect to IL-4 genotype distribution and allele frequencies (p<0.0001). The homozygous P1P1 genotype and P1 allele were significantly higher in FM patients than in healthy controls (p=0.04; OR: 3.25, 95% CI: 1-10, p<0.0001; OR:4.84, 95% CI:3-7.7). There was not any difference between the groups respect to IL-4 genotype distribution and allele frequencies (p>0.05) and clinical characteristics., Conclusion: Our findings suggest that there is an association of IL-4 gene 70 bp VNTR polymorphism with susceptibility of a person for development of FM. As a result, further studies are necessary to determine whether IL-4 may be a genetic marker for FM in the Turkish population., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.